# ArriVent BioPharma, Inc.: Form 8-K, filed Jul 21, 2025

- Company: [ArriVent BioPharma, Inc.](/companies/avbp.md) (CIK 1868279)
- Form: 8-K
- Filed: 2025-07-21
- Accepted by EDGAR: Jul 21, 2025, 08:08 ET
- Period: 2025-07-21
- Accession: 0001104659-25-069169
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1868279/000110465925069169/tm2521271d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1868279/000110465925069169/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1868279/000110465925069169/tm2521271d1_8k.htm

Filed Jul 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-069169. Last ingested by Listed: Nov 10, 2026, 02:46 ET. No prices; not investment advice.